Pentokey Organy (India) Ltd
Incorporated in 1986, Pentokey Organy (India) Ltd is engaged in trading organic chemicals.
- Market Cap ₹ 20.0 Cr.
- Current Price ₹ 32.0
- High / Low ₹ 64.5 / 27.5
- Stock P/E 80.2
- Book Value ₹ 15.0
- Dividend Yield 0.00 %
- ROCE 10.1 %
- ROE 9.86 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 157 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115.15 | 123.58 | 121.70 | 85.44 | 0.76 | 4.70 | 9.29 | 1.56 | 0.00 | 0.00 | 4.37 | 4.39 | 0.22 | |
107.51 | 121.68 | 122.45 | 88.66 | 2.59 | 5.31 | 10.10 | 2.25 | 0.54 | 0.41 | 3.52 | 3.95 | 0.47 | |
Operating Profit | 7.64 | 1.90 | -0.75 | -3.22 | -1.83 | -0.61 | -0.81 | -0.69 | -0.54 | -0.41 | 0.85 | 0.44 | -0.25 |
OPM % | 6.63% | 1.54% | -0.62% | -3.77% | -240.79% | -12.98% | -8.72% | -44.23% | 19.45% | 10.02% | -113.64% | ||
0.23 | 0.30 | 0.40 | 0.25 | 14.79 | 0.98 | 1.17 | 0.25 | 0.30 | 0.25 | 2.36 | 0.45 | 0.50 | |
Interest | 2.77 | 3.53 | 3.46 | 3.70 | 2.19 | 0.26 | 0.05 | 0.00 | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 |
Depreciation | 1.18 | 0.79 | 0.59 | 0.62 | 0.63 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 3.92 | -2.12 | -4.40 | -7.29 | 10.14 | 0.05 | 0.31 | -0.44 | -0.24 | -0.16 | 3.18 | 0.88 | 0.25 |
Tax % | 0.00% | 0.00% | 0.00% | 22.50% | 5.23% | 80.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
3.91 | -2.12 | -4.40 | -8.94 | 9.61 | 0.01 | 0.31 | -0.44 | -0.24 | -0.16 | 3.18 | 0.87 | 0.25 | |
EPS in Rs | 6.23 | -3.38 | -7.01 | -14.25 | 15.32 | 0.02 | 0.49 | -0.70 | -0.38 | -0.26 | 5.07 | 1.39 | 0.40 |
Dividend Payout % | 16.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -28% |
5 Years: | -14% |
3 Years: | % |
TTM: | -96% |
Compounded Profit Growth | |
---|---|
10 Years: | 9% |
5 Years: | 27% |
3 Years: | 78% |
TTM: | -76% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 37% |
3 Years: | 20% |
1 Year: | -40% |
Return on Equity | |
---|---|
10 Years: | -30% |
5 Years: | 10% |
3 Years: | 19% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 |
Reserves | 5.35 | 3.23 | -1.25 | -10.18 | -0.57 | -0.55 | -0.23 | -0.68 | -0.91 | -1.07 | 2.11 | 2.99 | 3.14 |
23.26 | 24.77 | 27.28 | 17.99 | 6.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
17.96 | 17.02 | 18.03 | 6.99 | 3.65 | 0.47 | 0.88 | 0.49 | 0.15 | 0.05 | 0.54 | 0.24 | 0.29 | |
Total Liabilities | 52.84 | 51.29 | 50.33 | 21.07 | 15.85 | 6.19 | 6.92 | 6.08 | 5.51 | 5.25 | 8.92 | 9.50 | 9.70 |
10.47 | 9.93 | 9.41 | 10.36 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.04 | 0.09 | 0.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 | 1.29 |
42.33 | 41.27 | 40.37 | 10.71 | 15.73 | 6.17 | 6.89 | 6.06 | 5.48 | 5.22 | 8.89 | 9.46 | 8.41 | |
Total Assets | 52.84 | 51.29 | 50.33 | 21.07 | 15.85 | 6.19 | 6.92 | 6.08 | 5.51 | 5.25 | 8.92 | 9.50 | 9.70 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-7.22 | 1.62 | 0.08 | 12.43 | -2.99 | 8.31 | -1.95 | 0.86 | 0.56 | -0.42 | -0.10 | 0.55 | |
-0.58 | -0.11 | 0.49 | -0.19 | 15.92 | -0.61 | 1.70 | -0.89 | -0.55 | 0.23 | 0.19 | -0.59 | |
7.78 | -1.07 | -0.70 | -12.42 | -13.16 | -7.29 | -0.01 | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 | |
Net Cash Flow | -0.02 | 0.44 | -0.13 | -0.17 | -0.23 | 0.42 | -0.25 | -0.03 | 0.01 | -0.19 | 0.06 | -0.04 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 23.27 | 29.68 | 26.57 | 0.81 | 0.00 | 15.53 | 86.44 | 224.62 | 12.53 | 157.14 | ||
Inventory Days | 47.59 | 47.58 | 50.84 | 2.19 | 93.37 | 6.77 | 11.10 | 0.00 | 23.95 | 0.00 | ||
Days Payable | 57.30 | 48.09 | 54.11 | 16.31 | 492.33 | 22.87 | 26.95 | 45.62 | ||||
Cash Conversion Cycle | 13.56 | 29.17 | 23.30 | -13.31 | -398.95 | -0.56 | 70.58 | 224.62 | -9.14 | 157.14 | ||
Working Capital Days | 49.92 | 35.65 | 49.94 | 10.30 | 5,249.28 | 226.77 | 122.19 | 299.49 | 283.98 | 273.54 | ||
ROCE % | 23.60% | 4.08% | -2.82% | -15.83% | -16.44% | -5.47% | -10.37% | -7.57% | -4.38% | -3.03% | 47.28% | 10.09% |
Documents
Announcements
- Result- Financial Result For The Quarter And Nine Months Ended 31St December, 2024 25 Jan
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th January, 2025
25 Jan - Independent auditor's review report on interim financial results.
-
Board Meeting Intimation for Approval Of Unaudited Financial Result For The Quarter And Nine Months Ended On 31St December, 2024.
22 Jan - Board meeting scheduled to approve Q3 financial results.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Jan - Certificate rceived in terms of 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended on 31st december, 2024 from RTA, Datamatics Business Solutions limited …
-
Closure of Trading Window
31 Dec 2024 - Closure of trading window from January 1, 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Portfolio:[1]
BUTYI Acetate Chemical, Ethyl Acetate, Acetaldehyde Chemical, Glacial Acetic Acid,
Extra Neutral Alcohol, Hand Sanitizer, Sodium Dihydrogen Phosphate, Cyanoacetyl Ethyl Urea, Sodium Dihydrogen SS, Ethyl Phenyl Acetate Chemical, Ethyl Chloro Acetoacetate, Ethyl Iso-cyanoacetate, Beauty Acetate, etc.